We confirmed a significant modulation of CLOCK, BMLA1 and NOTCH genes in glioma, particularly praising NOTCH genes family to be good as potentially attractive therapeutic targets for glioblastoma, strengthening the protective role observed in clinical trials for brain tumors. Here, CLOCK is linked to brain neoplasm.